FDA Raises Concerns Over Unapproved GLP-1 Drugs for Weight Loss | Retatrutide News

The FDA is concerned about the use of unapproved GLP-1 drugs, including Retatrutide, for weight loss. This highlights the importance of regulatory overs...
Market News · October 11, 2026